BioMed research international · 2017
Genetic and Epigenetic Regulation of Aortic Aneurysms.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kim Ha Won, Stansfield Brian K
Аннотация
Aneurysms are characterized by structural deterioration of the vascular wall leading to progressive dilatation and, potentially, rupture of the aorta. While aortic aneurysms often remain clinically silent, the morbidity and mortality associated with aneurysm expansion and rupture are considerable. Over 13,000 deaths annually in the United States are attributable to aortic aneurysm rupture with less than 1 in 3 persons with aortic aneurysm rupture surviving to surgical intervention. Environmental and epidemiologic risk factors including smoking, male gender, hypertension, older age, dyslipidemia, atherosclerosis, and family history are highly associated with abdominal aortic aneurysms, while heritable genetic mutations are commonly associated with aneurysms of the thoracic aorta. Similar to other forms of cardiovascular disease, family history, genetic variation, and heritable mutations modify the risk of aortic aneurysm formation and provide mechanistic insight into the pathogenesis of human aortic aneurysms. This review will examine the relationship between heritable genetic and epigenetic influences on thoracic and abdominal aortic aneurysm formation and rupture.
Предметные рубрики MeSH
AgedAgingAorta, ThoracicAortic Aneurysm, AbdominalAortic Aneurysm, ThoracicAortic RuptureDisease ProgressionEpigenesis, GeneticExtracellular MatrixFemaleGenetic Predisposition to DiseaseHumansInflammationLipidsMaleMarfan SyndromeModels, GeneticMuscle, SmoothMutationPolymorphism, Single NucleotideRisk FactorsSequence Analysis, DNASmokingTransforming Growth Factor beta